Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Methyldopa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Methyldopa 250mg tablets
0205020H0AAADAD
|
Methyldopa | Methyldopa | Cardiovascular System | 10,808 |
|
Methyldopa 500mg tablets
0205020H0AAAEAE
|
Methyldopa | Methyldopa | Cardiovascular System | 4,516 |
|
Methyldopa 125mg tablets
0205020H0AAACAC
|
Methyldopa | Methyldopa | Cardiovascular System | 2,226 |
|
Aldomet 500mg tablets
0205020H0BBACAE
|
Aldomet (Oral) | Methyldopa | Cardiovascular System | 184 |
|
Aldomet 250mg tablets
0205020H0BBABAD
|
Aldomet (Oral) | Methyldopa | Cardiovascular System | 170 |
|
Methyldopa 250mg/5ml oral suspension
0205020H0AAAIAI
|
Methyldopa | Methyldopa | Cardiovascular System | 6 |
|
Methyldopa 125mg/5ml oral liquid
0205020H0AAALAL
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Methyldopa 500mg/5ml oral suspension
0205020H0AAAHAH
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Methyldopa 50mg/5ml oral liquid
0205020H0AAAJAJ
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
|
Methyldopa 60mg/5ml oral liquid
0205020H0AAAKAK
|
Methyldopa | Methyldopa | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.